Clinical Trials
215 trialsVESTI
Aalto University
Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer
Alliance for Clinical Trials in Oncology
Studying the Workflow of the American College of Surgeons Geriatric Surgery Program to Improve Clinical Outcomes in Older Adults Undergoing Surgery at the James Cancer Hospital
Ohio State University Comprehensive Cancer Center
Peds IMPACT
University of Florida
Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer
University of California, San Francisco
Measuring Brain Changes Following Cognitive Intervention in Pediatric Patients With Brain Tumors
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
FET-BRAIN-DX
IRCCS San Raffaele
PIRe
Rigshospitalet, Denmark
VBS-CSI-PT-PED
Ruijin Hospital
Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
Washington University School of Medicine
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
M.D. Anderson Cancer Center
Gait in Young Children With NF1
NYU Langone Health
EViDENCE-BT
University of Zurich
SHAM INDYGO/DO
University Hospital, Lille
IMPACT MET
University of Florida
APATC
Center Eugene Marquis
BALANCE
Duke University
MELODY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
NRG Oncology
MRinRT
Swansea Bay University Health Board
FCI-Glioblastoma Study
University of Aberdeen
Brain Radiotherapy Combined With Dalpiciclib and Endocrine Therapy in HR-Positive/HER2-Negative Advanced Breast Cancer With Brain Metastases
Nanfang Hospital, Southern Medical University
BRiTE
Duke University
MeFAMP for Imaging System A Amino Acid Transport in Primary and Metastatic Brain Tumors
University of Alabama at Birmingham
Zorifertinib Plus Intra-Ommaya CSF Chemotherapy for Leptomeningeal Progression in NSCLC After Third-Generation EGFR-TKI
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
T-BRAIN
Maastricht University Medical Center
STARGATE
University Hospital, Essen
Sitagliptin in Recurrent/Progressive Grade 4 Glioma
University of Iowa
Comparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases:
The Second Affiliated Hospital of Hainan Medical University
Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5
Shaare Zedek Medical Center
APT-HGG
IRCCS Ospedale San Raffaele
A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma
M.D. Anderson Cancer Center
Postoperative Neurological Recovery and Risk Factor Analysis in Patients With Paralysis Due to Spinal Metastases
Shanghai Changzheng Hospital
The Effect of Radiotherapy After Separation Surgery for Spinal Metastases
Shanghai Changzheng Hospital
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Mayo Clinic
SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases
National Taiwan University Hospital
NF118
University of Alabama at Birmingham
Effect of Perioperative Ulinastatin on Postoperative Stroke in Patients With Brain Tumor
Beijing Tiantan Hospital
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
Nationwide Children's Hospital
Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)
Case Comprehensive Cancer Center
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
Dana-Farber Cancer Institute
ThINKK-01
St. Justine's Hospital
Oral Gallium Maltolate for Recurrent Glioblastoma
Medical College of Wisconsin
Prospective Cohort Study of Pheochromocytoma/Paraganglioma
Peking Union Medical College Hospital
A Phase II Clinical Study of Utidelone and Bevacizumab With or Without Etoposide in Patients With Brain Metastases From Malignant Solid Tumors
Tianjin Medical University Cancer Institute and Hospital
Use of Shear Wave Elastography for Intraoperative Brain and Tumor Stiffness Measurements
Mayo Clinic
A Phase I, Single-arm, Open-label Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of CHT101 Cell Infusion in Adult Subjects With Recurrent or Progressive Malignant Primary Brain Tumors（CROWN）
Tianjin Medical University Cancer Institute and Hospital
HipoGBM
Hospital do Coracao
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Vanderbilt-Ingram Cancer Center
A Study for Cerebral Open Flow Microperfusion
Mayo Clinic